• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Swedish Digital Healthcare Company Doktor.se Announces €50M Funding Boost

Share:

June 8, 2021

Stockholm-based digital healthcare provider Doktor.se has received a funding boost of €50 million (SEK510 million) to expand its services and deliver its aim to provide safe and accessible healthcare for all.

The funding round included institutional investors Consensus Asset Management, Norron, and Skabholmen Invest.

Due to high demand from new and existing investors, early Doktor.se investor Oriola Corporation agreed to sell a part of their shares on top of the new capital. Oriola remains one of the largest shareholders in Doktor.se.

WHY IT MATTERS

Doktor.se is the second most downloaded doctor app in Europe, according to app analytics tool Appfigures. By the end of 2021, the Swedish company aims to provide its digital health services in more than seven countries.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The new funds will be used to develop its technology platform to offer improved services for mental health and chronic illnesses and to expand its digital operations and physician clinics to meet growing demand.

Over 1.2 million patient consultations were carried out through its app or its physical clinics in 2020. The company is now looking to expand further into new markets and to investigate strategic acquisitions.

The company also plans to keep expanding its Digi-physical services by acquiring physical healthcare services to integrate into its digital platforms.

Doktor.se recently began operations in Belgium in a partnership with Proximus Group, one of Belgium’s main providers of digital services and communication solutions. As part of its plans to expand globally, Doktor.se previously established partnerships with ViBE, the largest digital healthcare provider in Brazil, and AniCura, a digital vet app available across the Nordics.

THE LARGER CONTEXT

In recent funding news, IVF automation startup Overture Life has raised $15 million (€12.3M) in Series B funding led by Octopus Ventures. The Madrid-based startup has now raised a total of $37 million (€30M) in support of its mission to revolutionize embryology and make IVF more accessible.

ON THE RECORD

“Our mission is to provide the technology which enables safe and accessible healthcare for everyone, making the experience frictionless and efficient,” said Martin Lindman, CEO, and co-founder of Doktor.se.

“By making the first contact with patients digital, we save time and resources for the individual and our society at large. More patients receive care faster, while traditional healthcare is relieved. This frees up resources for patients who really need physical appointments. That is why we are so proud to offer this combination of physical and digital healthcare to people and where we believe we can really make a difference,” he added.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Dr. Reddy’s Laboratories Announces the Sale of Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, TennesseeDr. Reddy’s Laboratories Announces the Sale of Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, Tennessee
  • Iodine Acquires Clinical Documentation Solution ChartWise – Health M&AIodine Acquires Clinical Documentation Solution ChartWise – Health M&A
  • Singaporean Scientists Develop AI System for Screening GlaucomaSingaporean Scientists Develop AI System for Screening Glaucoma
  • Pharos Capital’s Complete Health Acquires Birmingham Internal Medicine AssociatesPharos Capital’s Complete Health Acquires Birmingham Internal Medicine Associates
  • GW Pharmaceuticals Shareholders Approve Acquisition By Jazz PharmaceuticalsGW Pharmaceuticals Shareholders Approve Acquisition By Jazz Pharmaceuticals
  • Waystar Acquires Patient Payment Platform Healthpay24Waystar Acquires Patient Payment Platform Healthpay24
  • AWAK Bags $20M in Series B Funding and More BriefsAWAK Bags $20M in Series B Funding and More Briefs
  • Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity AsiaBoston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications